Zydus receives US FDA tentative nod for Losartan tabs (PharmaBiz)
Zydus Cadila has received tentative approval for the Losartan potassium tablets from the US FDA. The strengths of the tablets is 25 mg, 50 mg and 100 mg The branded sales of Losartan potassium tablets, which falls in the anti-hypertensive segment, is estimated at USD 817 million in 2006 as per NDC Health.

The Danger In Dendreon (Forbes)
Why the prostate cancer-fighting biotech is an extremely risky investment.